Press Releases
Site - Investor Relations
Predictive Oncology Exchanges $2.1 Million of Debt for Equity, Streamlining Capital Structure and Simplifying Balance Sheet
Under the agreement,
The Company received and cancelled outstanding debt of
Additional details regarding the agreement can be found at www.sec.gov on the Company’s Form 8-K filed with the
About
Forward-Looking Statements
Certain of the matters discussed in this press release contain forward-looking statements that involve material risks to and uncertainties in the Company’s business that may cause actual results to differ materially from those anticipated by the statements made herein. Such risks and uncertainties include: we may not be able to continue operating without additional financing; current negative operating cash flows; the terms of any further financing, which may be highly dilutive and may include onerous terms; risks related to the 2019 merger with
Investor Relations Contact:
Hayden IR
James Carbonara
(646)-755-7412
james@haydenir.com
Source: Predictive Oncology Inc.